<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Infectious complications resulting from resection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) elevates the risk of <z:e sem="disease" ids="C0920420" disease_type="Neoplastic Process" abbrv="">cancer recurrence</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, but the reason for this risk relationship is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Defining the mechanisms responsible may offer opportunities to improve outcomes in a majority of patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are resected as part of their therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The complex formed between Toll receptor TLR4 and myeloid differentiation factor MD2 defines a major cell surface receptor for <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS), a <z:mp ids='MP_0001795'>gram-negative</z:mp> <z:mp ids='MP_0001794'>bacterial</z:mp> antigen that has been implicated in infectious complications after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> resection </plain></SENT>
<SENT sid="3" pm="."><plain>As the TLR4/MD2 complex is expressed on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, we hypothesized that LPS may promote <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> by stimulating TLR4 signaling </plain></SENT>
<SENT sid="4" pm="."><plain>In support of this hypothesis, we report here that LPS enhances <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells that express TLR4/MD2 after intrasplenic graft of immunocompromised <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with TLR4 nonexpressing, nonmetastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, we observed increased in vitro adherence to different extracellular matrices and human umbilical vein endothelial cells (HUVEC) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, we observed an increased likelihood of in vivo capture within hepatic sinusoids after LPS treatment </plain></SENT>
<SENT sid="7" pm="."><plain>No differences were apparent in phosphorylation of p38 and MAPK isoforms, but in metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells expressing surface TLR4 treatment with LPS increased Ser473 phosphorylation of AKT kinase </plain></SENT>
<SENT sid="8" pm="."><plain>We showed that enhanced adherence elicited by LPS in these cells could be blocked at three different levels, using Eritoran (TLR4 small molecule <z:chebi fb="68" ids="48706">antagonist</z:chebi>), PI-103 (PI3K inhibitor), or anti-β1 integrin blocking antibodies </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, the results indicate that stimulation of the TLR4/MD2 complex by LPS activates PI3K/AKT signaling and promotes downstream β1 integrin function, thereby increasing the adhesiveness and metastatic capacity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="10" pm="."><plain>Our findings suggest that inhibiting LPS-induced TLR4 signaling could improve therapeutic outcomes by preventing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> during the perioperative period of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> resection </plain></SENT>
</text></document>